# Celyad Oncology S.A. (CLYYF)

> Healthcare · BE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLYYF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 21.3K | € 841.9K | € -7.60M | € 0 | € 2.44M |
| 2024 | € 192.7K | € -6.03M | € -5.88M | € 17.54M | € -16.12M |
| 2023 | € 108.2K | € -8.96M | € -17.12M | € 902.0K | € 6.30M |
| 2022 | € 0 | € -36.43M | € -30.72M | € 16.89M | € -12.31M |
| 2021 | € 0 | € -12.43M | € -32.24M | € 2.63M | € 43.64M |
| 2020 | € 6.3K | € -14.74M | € -35.03M | € 3.64M | € 30.99M |
| 2019 | € 7.5K | € -35.74M | € -35.97M | € 4.36M | € 45.62M |
| 2018 | € 3.94M | € -47.34M | € -35.52M | € 1.65M | € 55.59M |
| 2017 | € 4.55M | € -72.42M | € -58.16M | € 1.44M | € 47.54M |
| 2016 | € 11.09M | € -30.72M | € -36.36M | € 1.48M | € 90.88M |
| 2015 | € 3.9K | € -38.30M | € -36.99M | € 675.0K | € 111.47M |
| 2014 | € 192.6K | € -21.70M | € -23.75M | € 413.0K | € 26.68M |
| 2013 | € 8.40M | € -19.08M | € -14.10M | € 106.4K | € 16.90M |
| 2012 | € 71.7K | € -2.86M | € -9.68M | € 921.4K | € -1.31M |
| 2011 | € 35.8K | € -6.78M | € -15.73M | € 116.3K | € 840.1K |
| 2010 | € 2.06M | € -9.11M | € -11.36M | € 291.0K | € 8.69M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.76 |
| Current Ratio | 1.92 |

## Other views

- [Metrics](https://sponda.capital/en/CLYYF.md)
- [Charts](https://sponda.capital/en/CLYYF/charts.md)
- [Compare](https://sponda.capital/en/CLYYF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.